Effect of Zoledronic Acid on Femoral Bone Loss Following Total Hip Arthroplasty

Summary

In a randomized, double-blind trial, BMD of the operated proximal femur after total hip replacement measured by dual-energy x-ray absorptiometry (DXA) were compared for up to two years in patients receiving IV ZOL 5 mg infusion (n = 27) or placebo (IV saline infusion; n = 24) at two weeks and one year after surgery.

Timeline

Start

2005-01

Primary completion

2014-12

Completion

2014-12

Drugs

Indications